quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:54:17·162d
ANALYSTRating
Brighthouse Financial Inc. logo

Brighthouse Financial downgraded by Raymond James

BHF· Brighthouse Financial Inc.
Finance
Original source

Companies

  • BHF
    Brighthouse Financial Inc.
    Finance

Recent analyst ratings

  • Jan 8UpdateBarclays$65.00
  • Nov 12UpdateRaymond James-
  • Mar 18UpdateRaymond James$72.00
  • Feb 19UpdateWells Fargo$59.00
  • Feb 3UpdateJefferies$64.00
  • Jan 29UpdateBarclays$85.00

Related

  • SEC9d
    SEC Form DEFA14A filed by Brighthouse Financial Inc.
  • SEC9d
    SEC Form DEF 14A filed by Brighthouse Financial Inc.
  • INSIDER14d
    SEC Form 4 filed by Pavlovich Melissa B.
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Brighthouse Financial Inc.
  • INSIDER52d
    Chief Accounting Officer Pavlovich Melissa B. was granted 1,302 shares, covered exercise/tax liability with 856 shares and converted options into 1,383 shares, increasing direct ownership by 27% to 8,651 units (SEC Form 4)
  • INSIDER52d
    President and CEO Steigerwalt Eric T was granted 75,577 shares, covered exercise/tax liability with 43,736 shares and converted options into 35,564 shares, increasing direct ownership by 22% to 374,641 units (SEC Form 4)
  • INSIDER52d
    EVP & Chief Financial Officer Spehar Edward A. was granted 18,786 shares, covered exercise/tax liability with 15,373 shares and converted options into 13,658 shares, increasing direct ownership by 36% to 64,413 units (SEC Form 4)
  • INSIDER52d
    EVP & General Counsel Lin Allie was granted 8,974 shares, covered exercise/tax liability with 7,035 shares and converted options into 7,072 shares, increasing direct ownership by 140% to 15,462 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022